BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28928113)

  • 1. PDK4 Inhibits Cardiac Pyruvate Oxidation in Late Pregnancy.
    Liu LX; Rowe GC; Yang S; Li J; Damilano F; Chan MC; Lu W; Jang C; Wada S; Morley M; Hesse M; Fleischmann BK; Rabinowitz JD; Das S; Rosenzweig A; Arany Z
    Circ Res; 2017 Dec; 121(12):1370-1378. PubMed ID: 28928113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coenzyme A-mediated degradation of pyruvate dehydrogenase kinase 4 promotes cardiac metabolic flexibility after high-fat feeding in mice.
    Schafer C; Young ZT; Makarewich CA; Elnwasany A; Kinter C; Kinter M; Szweda LI
    J Biol Chem; 2018 May; 293(18):6915-6924. PubMed ID: 29540486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4.
    Mori J; Alrob OA; Wagg CS; Harris RA; Lopaschuk GD; Oudit GY
    Am J Physiol Heart Circ Physiol; 2013 Apr; 304(8):H1103-13. PubMed ID: 23396452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression.
    Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR
    Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons.
    Khairallah M; Labarthe F; Bouchard B; Danialou G; Petrof BJ; Des Rosiers C
    Am J Physiol Heart Circ Physiol; 2004 Apr; 286(4):H1461-70. PubMed ID: 14670819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation.
    Sharma N; Okere IC; Brunengraber DZ; McElfresh TA; King KL; Sterk JP; Huang H; Chandler MP; Stanley WC
    J Physiol; 2005 Jan; 562(Pt 2):593-603. PubMed ID: 15550462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation.
    Grassian AR; Metallo CM; Coloff JL; Stephanopoulos G; Brugge JS
    Genes Dev; 2011 Aug; 25(16):1716-33. PubMed ID: 21852536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy.
    Zhao G; Jeoung NH; Burgess SC; Rosaaen-Stowe KA; Inagaki T; Latif S; Shelton JM; McAnally J; Bassel-Duby R; Harris RA; Richardson JA; Kliewer SA
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H936-43. PubMed ID: 18083902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of the mammalian pyruvate dehydrogenase kinases in the prevention of hyperglycaemia.
    Sugden MC; Holness MJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):151-65. PubMed ID: 12476789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
    Liepinsh E; Makrecka M; Kuka J; Makarova E; Vilskersts R; Cirule H; Sevostjanovs E; Grinberga S; Pugovics O; Dambrova M
    Metabolism; 2014 Jan; 63(1):127-36. PubMed ID: 24140100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats.
    Abdel-aleem S; Karim AM; Zarouk WA; Taylor DA; el-Awady MK; Lowe JE
    Horm Metab Res; 1997 Sep; 29(9):430-5. PubMed ID: 9370110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of cardiac glucose metabolism in association to low birth weight: experimental evidence in lambs with left ventricular hypertrophy.
    Wang KC; Lim CH; McMillen IC; Duffield JA; Brooks DA; Morrison JL
    Metabolism; 2013 Nov; 62(11):1662-72. PubMed ID: 23928106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift.
    Wang L; Ko KW; Lucchinetti E; Zhang L; Troxler H; Hersberger M; Omar MA; Posse de Chaves EI; Lopaschuk GD; Clanachan AS; Zaugg M
    Anesthesiology; 2010 Sep; 113(3):541-51. PubMed ID: 20683255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis.
    Song X; Liu J; Kuang F; Chen X; Zeh HJ; Kang R; Kroemer G; Xie Y; Tang D
    Cell Rep; 2021 Feb; 34(8):108767. PubMed ID: 33626342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-inflammatory Macrophages Sustain Pyruvate Oxidation through Pyruvate Dehydrogenase for the Synthesis of Itaconate and to Enable Cytokine Expression.
    Meiser J; Krämer L; Sapcariu SC; Battello N; Ghelfi J; D'Herouel AF; Skupin A; Hiller K
    J Biol Chem; 2016 Feb; 291(8):3932-46. PubMed ID: 26679997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose transport and glucose transporter GLUT4 are regulated by product(s) of intermediary metabolism in cardiomyocytes.
    Fischer Y; Böttcher U; Eblenkamp M; Thomas J; Jüngling E; Rösen P; Kammermeier H
    Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):629-38. PubMed ID: 9032447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest.
    Reed MK; Barak C; Malloy CR; Maniscalco SP; Jessen ME
    J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1651-60. PubMed ID: 8975857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of substrate utilization by the mitochondrial pyruvate carrier.
    Vacanti NM; Divakaruni AS; Green CR; Parker SJ; Henry RR; Ciaraldi TP; Murphy AN; Metallo CM
    Mol Cell; 2014 Nov; 56(3):425-435. PubMed ID: 25458843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-fatty acid cycle to inhibit glucose utilization and oxidation is not operative in fatty acid-cultured islets.
    Liu YQ; Tornheim K; Leahy JL
    Diabetes; 1999 Sep; 48(9):1747-53. PubMed ID: 10480604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.
    Go Y; Jeong JY; Jeoung NH; Jeon JH; Park BY; Kang HJ; Ha CM; Choi YK; Lee SJ; Ham HJ; Kim BG; Park KG; Park SY; Lee CH; Choi CS; Park TS; Lee WN; Harris RA; Lee IK
    Diabetes; 2016 Oct; 65(10):2876-87. PubMed ID: 27385159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.